Autonomous continuous processing transforms API manufacturing with inline NMR, AI-driven control, and real-time optimization ...

Claude is Anthropic’s AI assistant for writing, coding, analysis, and enterprise workflows, with newer tools such as Claude ...

HOUSTON, March 26, 2026 /PRNewswire/ -- Milagro, a leader in autonomous surgical coding and denial prevention technology, announces a strategic collaboration with BRSi, a nationally recognized leader ...

RALEIGH, N.C., March 24, 2026 /PRNewswire/ -- Medaptus, a leading provider of healthcare technology solutions, today announced that Rush University System for Health has selected Medaptus' Charge ...

Summer is coming! It may be spring break now but school will be out on May 22. Make your plans with our 2026 guide to Tallahassee area summer camps to keep your kids entertained and educated. If you ...

Many artificial intelligence startup ideas are still little more than superficial “wrappers” built on top of existing models. But as the AI model makers add more features, investors are wary of ...

Ben Shoemaker works at Elanco Animal Health’s Innovation Center, which is part of its headquarters campus downtown. Elanco anchors the developing OneHealth Innovation District at the former General ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America Securities reiterated a Hold rating on Recursion Pharmaceuticals, Inc.

First solution—Malnutrition Care Automation—generates $1.4M in annualized reimbursement for southern academic medical center by identifying missed diagnoses, orchestrating timely care and completing ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most promising penny stocks under $5 to buy. On February 25, Recursion Pharmaceuticals reported its financial results for Q4 and the full ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

As India pivots from software services to AI token "factories" with tax breaks for global firms, questions arise over jobs, ...